Optilite Rheumatoid Factor Kit— 510(k) K162263

Substantially Equivalent

The Binding Site Group , Ltd.

FDA 510(k) clearance K162263 for Optilite Rheumatoid Factor Kit, Substantially Equivalent on 2017-05-03. Applicant: The Binding Site Group , Ltd.. Device class: 2.

Clearance details

Applicant
The Binding Site Group , Ltd.
Product code
Code DHR
Device class
Class 2
Regulation
21 CFR 866.5775
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Birmingham, GB
Download summary PDFView on FDA.gov ↗

Recent devices under product code DHR

view all

More clearances from The Binding Site Group , Ltd.

view all

Recalls naming K162263

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K162263.

Data sourced from openFDA. This site is unofficial and independent of the FDA.